Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6RZ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,069
Award facts
- Contract value 100% obligated
- $24,069.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,069.18 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Zepbound 12.5 mg/0.5 mL pen injections, with completion scheduled for January 6, 2026. This non-competitive, firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical supply chain solutions for military and veteran healthcare systems. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This delivery order represents a routine pharmaceutical procurement within AmerisourceBergen's extensive federal contract portfolio, which demonstrates consistent capability in fulfilling competitive federal medical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F6RZ1?
SPE2DR26F6RZ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F6RZ1 worth?
The government has obligated $24,069 on SPE2DR26F6RZ1.
Is contract SPE2DR26F6RZ1 an order under another contract?
Yes. SPE2DR26F6RZ1 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6RZ1 competed?
The extent of competition for SPE2DR26F6RZ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award